M A22 (Alprazolam extended-release 1 mg)

Pill imprint M A22 has been identified as Alprazolam extended-release 1 mg.

Alprazolam is used in the treatment of anxiety; panic disorder; depression; tinnitus; dysautonomia and belongs to the drug class benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Alprazolam 1 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.

See also related documents.

Images for M A22 (Alprazolam extended-release 1 mg)

Alprazolam extended-release 1 mg M A22
Alprazolam extended-release 1 mg M A22
Alprazolam extended-release
Imprint:
M
A22
Strength:
1 mg
Color:
Orange
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Benzodiazepines
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-5022
Inactive Ingredients:
silicon dioxide
hypromelloses
lactose
magnesium stearate
microcrystalline cellulose
FD&C Yellow No. 6

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web1)